Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity.

Hotopf M, Hardy R, Lewis G.

Br J Psychiatry. 1997 Feb;170:120-7.

PMID:
9093499
[PubMed - indexed for MEDLINE]
2.

Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials.

Barbui C, Hotopf M.

Br J Psychiatry. 2001 Feb;178:129-44. Review.

PMID:
11157426
[PubMed - indexed for MEDLINE]
Free Article
3.

WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).

Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD002791. Review.

PMID:
17636706
[PubMed - indexed for MEDLINE]
4.

Meta-analytical studies on new antidepressants.

Anderson IM.

Br Med Bull. 2001;57:161-78. Review.

PMID:
11719915
[PubMed - indexed for MEDLINE]
5.

Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.

Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM.

Cochrane Database Syst Rev. 2000;(4):CD002791. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD002791.

PMID:
11034764
[PubMed - indexed for MEDLINE]
6.

A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.

Williams JW Jr, Mulrow CD, Chiquette E, Noël PH, Aguilar C, Cornell J.

Ann Intern Med. 2000 May 2;132(9):743-56. Review.

PMID:
10787370
[PubMed - indexed for MEDLINE]
7.

Treatment of depression--newer pharmacotherapies.

Mulrow CD, Williams JW Jr, Trivedi M, Chiquette E, Aguilar C, Cornell JE, Badgett R, Noël PH, Lawrence V, Lee S, Luther M, Ramirez G, Richardson WS, Stamm K.

Psychopharmacol Bull. 1998;34(4):409-795. Review.

PMID:
10513454
[PubMed - indexed for MEDLINE]
8.

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.

Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New Generation Antidepressants (MANGA) Study Group.

J Clin Psychiatry. 2008 Sep;69(9):1404-15. Review.

PMID:
19193341
[PubMed - indexed for MEDLINE]
9.

How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?

Hall WD, Lucke J.

Aust N Z J Psychiatry. 2006 Nov-Dec;40(11-12):941-50. Review.

PMID:
17054562
[PubMed - indexed for MEDLINE]
10.

Amitriptyline for depression.

Guaiana G, Barbui C, Hotopf M.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004186. Review.

PMID:
17636748
[PubMed - indexed for MEDLINE]
11.

Are SNRIs more effective than SSRIs? A review of the current state of the controversy.

Thase ME.

Psychopharmacol Bull. 2008;41(2):58-85. Review.

PMID:
18668017
[PubMed - indexed for MEDLINE]
12.

Amitriptyline versus other types of pharmacotherapy for depression.

Guaiana G, Barbui C, Hotopf M.

Cochrane Database Syst Rev. 2003;(2):CD004186. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD004186.

PMID:
12804503
[PubMed - indexed for MEDLINE]
13.

Amitriptyline for inpatients and SSRIs for outpatients with depression? Systematic review and meta-regression analysis.

Barbui C, Guaiana G, Hotopf M.

Pharmacopsychiatry. 2004 May;37(3):93-7. Review.

PMID:
15179966
[PubMed - indexed for MEDLINE]
14.

Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.

Ruhé HG, Huyser J, Swinkels JA, Schene AH.

J Clin Psychiatry. 2006 Dec;67(12):1836-55. Review.

PMID:
17194261
[PubMed - indexed for MEDLINE]
15.

Efficacy of newer medications for treating depression in primary care patients.

Mulrow CD, Williams JW Jr, Chiquette E, Aguilar C, Hitchcock-Noel P, Lee S, Cornell J, Stamm K.

Am J Med. 2000 Jan;108(1):54-64. Review.

PMID:
11059441
[PubMed - indexed for MEDLINE]
16.

Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.

MacGillivray S, Arroll B, Hatcher S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I.

BMJ. 2003 May 10;326(7397):1014. Review.

PMID:
12742924
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.

Smith D, Dempster C, Glanville J, Freemantle N, Anderson I.

Br J Psychiatry. 2002 May;180:396-404. Review.

PMID:
11983635
[PubMed - indexed for MEDLINE]
Free Article
18.

Acute therapy of depression.

Bech P.

J Clin Psychiatry. 1993 Aug;54 Suppl:18-27; discussion 28. Review.

PMID:
8253702
[PubMed - indexed for MEDLINE]
19.

Fluoxetine. A pharmacoeconomic review of its use in depression.

Wilde MI, Benfield P.

Pharmacoeconomics. 1998 May;13(5 Pt 1):543-61. Review.

PMID:
10180753
[PubMed - indexed for MEDLINE]
20.

New goals in the treatment of depression: moving toward recovery.

Thase ME, Ninan PT.

Psychopharmacol Bull. 2002 Summer;36 Suppl 2:24-35. Review.

PMID:
12490821
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk